Advertisement

Topics

Navidea Enters Exclusive License and Distribution Agreement For India with Sayre Therapeutics

10:37 EDT 20 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Tc 99m Tilmanocept Already Commercialized in Three Major European Countries Represents Next-Generation Standard of Diagnosis For Sentinel Lymph Node Detection Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB)...

Other Sources for this Article

Navidea Biopharmaceuticals
Jed Latkin, CFO/COO, 614-551-3416
jlatkin@navidea.com
or
Edison Advisors
Tirth Patel, 646-653-7035
tpatel@edisongroup.com

NEXT ARTICLE

More From BioPortfolio on "Navidea Enters Exclusive License and Distribution Agreement For India with Sayre Therapeutics"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open http://www.bioportfolio.com/channels?category_id=5 Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...